1 |
Liu GY, Ventura IB, Achtar-Zadeh N, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis [J]. Chest, 2019, S0012-3692(19): 31132-311328.
|
2 |
Kang S, Cho MH, Hyun H, et al. A pediatric case of a D-Penicillamine induced ANCA-associated vasculitis manifesting a pulmonary-renal syndrome [J]. J Korean Med Sci, 2019, 34(24): e173.
|
3 |
Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference [J]. Arthritis Rheum, 1994, 37(2): 187-192.
|
4 |
Yoo J, Kim HJ, Ahn SS, et al. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis [J]. Clin Exp Rheumatol, 2018, Suppl 111(2): 85-87.
|
5 |
黎磊石, 刘志红. 中国肾脏病学 [M]. 北京: 人民军医出版社, 2008.
|
6 |
王卫平. 儿科学 [M]. 北京: 人民卫生出版社, 2013.
|
7 |
Jariwala MP, Laxer RM. Primary vasculitis in childhood: GPA and MPA in childhood [J]. Front Pediatr, 2018, 16(6): 226.
|
8 |
Mossberg M, Segelmark M, Kahn R, et al. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden [J]. Scand J Rheumatol, 2018, 47(4): 295-302.
|
9 |
Lee JJY, Alsaleem A, Chiang GPK, et al. Hallmark trials in ANCA~associated vasculitis (AAV) for the pediatric rheumatologist [J]. Pediatr Rheumatol Online J, 2019, 17(1): 31.
|
10 |
Li J, Cui Z, Long JY, et al. The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China [J]. Arthritis Res Ther, 2018, 20(1): 226.
|
11 |
Plumb LA, Oni L, Marks SD, et al. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management [J]. Pediatr Nephrol, 2018, 33(1): 25-39.
|
12 |
Ghang B, Lee J, Chan Kwon O, et al. Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis [J]. Respir Med, 2019, 7(155): 43-48.
|
13 |
Katikineni VS, Kant S, Gapud EJ, et al. Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes [J]. Clin Rheumatol, 2019, 38(8): 2195-2199.
|
14 |
Berti A, Boukhlal S, Groh M, et al. Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease [J]. Expert Rev Clin Immunol, 2020, 16(1): 51-61.
|
15 |
Yang L, Xie H, Liu Z, et al. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study [J]. BMC Nephrol, 2018, 19(1): 138.
|
16 |
Ohlsson S, Holm L, Hansson C, et al. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation [J]. PLoS One, 2019, 14(6): e0218272.
|
17 |
Antovic A, Mobarrez F, Manojlovic M, et al. Microparticles expressing myeloperoxidase and complement C3a and C5a as markers of renal involvement in antineutrophil cytoplasmic antibody-associated vasculitis [J]. J Rheumatol, 2020, 47(5): 714-721.
|
18 |
Wu EY, McInnis EA, Boyer-Suavet S, et al. Measuring circulating complement activation products in myeloperoxidase and proteinase 3 antineutrophil cytoplasmic antibody vasculitis [J]. Arthritis Rheumatol, 2019, 71(11): 1894-1903.
|
19 |
Lilliebladh S, Johansson A, Pettersson A, et al. Phenotypic characterization of circulating CD4+ T cells in ANCA-associated vasculitis [J]. J Immunol Res, 2018, 11(30): 6984563.
|
20 |
Sacoto G, Boukhlal S, Specks U, et al. Lung involvement in ANCA-associated vasculitis [J]. Presse Med, 2020, 49(3): 104039.
|
21 |
Sayad E, Vogel TP, Cortes-Santiago N, et al. Lung biopsy in the diagnosis of pediatric ANCA-associated vasculitis [J]. Pediatr Pulmonol, 2021, 56(1): 145-152.
|
22 |
Buda N, Masiak A, Zdrojewski Z. Utility of lung ultrasound in ANCA-associated vasculitis with lung involvement [J]. PLoS One, 2019, 14(9): e0222189.
|
23 |
Liu GY, Ventura IB, Achtar-Zadeh N, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis [J]. Chest, 2019, 156(4): 715-723.
|
24 |
Sebastiani M, Manfredi A, Vacchi C, et al. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis [J]. Clin Exp Rheumatol, 2020, Suppl 124(2): 221-231.
|
25 |
Watanabe T, Minezawa T, Hasegawa M, et al. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study [J]. BMC Pulm Med, 2019, 19(1): 194.
|
26 |
Borie R,Crestani B. Antineutrophil cytoplasmic antibody-associated lung fibrosis [J]. Semin Respir Crit Care Med, 2018, 39(4): 465-470.
|